AI assistant
Co-Diagnostics, Inc. — Director's Dealing 2025
Nov 24, 2025
35011_dirs_2025-11-24_b8fc5951-5b4b-4f36-ae5e-a91d6671039c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Co-Diagnostics, Inc. (CODX)
CIK: 0001692415
Period of Report: 2025-11-23
Reporting Person: Abbott Richard David (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-11-23 | Common Stock | A | 56667.00 | $0.00 | Acquired | 83402.00 | Direct |
| 2025-11-23 | Common Stock | D | 17200.00 | $0.35 | Disposed | 66202.00 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-11-23 | Restricted Stock Unit | $0.00 | M | 56667.00 | Disposed | Common Stock (350438.00) | Direct |
Footnotes
F1: Included in 120,000 restricted stock units awarded to the Reporting Person on April 26, 2024, pursuant to the Co-Diagnostics, Inc. 2015 Long Term Incentive Plan, and vest in 6 equal installments every 6 months commencing on November 23, 2024. Included in 220,000 restricted stock units awarded to the Reporting Person on August 13, 2025, pursuant to the Co-Diagnostics, Inc. 2015 Long Term Incentive Plan, and vest in 6 equal installments every 6 months commencing on November 23, 2025.
F2: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSU's. This sale is mandated by the Issuer's election, under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.